Editorial Type:
Article Category: Research Article
| Online Publication Date: 09 Nov 2011
A Protocol and Pilot Study for Managing Fibromyalgia with Yoga and Meditation
A Protocol and Pilot Study for Managing Fibromyalgia with Yoga and Meditation
Page Range: 109 – 121
Fibromyalgia is a chronic syndrome characterized by widespread pain, sleep disturbance, stiffness, fatigue,headache, and mood disorders. Recent research has resulted in an improved understanding of fibromyalgia and its possible causes. This article highlights some of the current research, discusses a strategy for using yoga and meditation as a therapy for fibromyalgia sufferers, and presents the results of a preliminary 8-week study using yoga and meditation to help manage fibromyalgia symptoms. The study of 11 participants found significant improvement in the overall health status of the participants and in symptoms of stiffness, anxiety, and depression. Significant improvements were also seen in the reported number of days "felt good" and number of days "missed work" because of fibromyalgia. Nonsignificant improvements were seen in measures of pain, fatigue, and how one felt in the morning. Effect sizes were medium to large for most tested areas. This study supports the benefits of yoga and meditation for individuals with fibromyalgia and encourages further research to explore their use as standard therapies for fibromyalgia.
Keywords: yoga; fibromyalgia; chronic pain; fatigue; mood; meditation; relaxation; breathing; anxiety; depression
Wolfe F, Smythe HA, Yunus MB, et al. The American college of rheumatology criteria for the classification of fibromyalgia. Arthritis & Rheumatism. 1990;33:160-172.
National Institutes of Health. Fibromyalgia. http://health.nih.gov/topic/Fibromyalgia
Sicras-Mainar A, Rejas J, Navarro R, et al. Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthritis Research and Therapy. 2009;11:R54. doi:10.1186/ar2673.
Wallace DJ, Clauw DJ. Fibromyalgia: the essential clinician's guide. New York: Oxford University Press; 2010.
Rossy LA, Buckelew SP, Dorr N, et al. A meta-analysis of fibromyalgia treatment interventions. Annals of Behavioral Medicine. 1999;21:180-191.
Lind BK, Lafferty WE, Tyree PT, Diehr PK, Grembowski DE. Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage. Arthritis and Rheumatism. 2007;57:71-76. doi:10.1002/art.22471.
Lind BK, Lafferty WE, Tyree PT, Diehr PK, Grembowski DE. Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage. Arthritis and Rheumatism. 2007;57:71-76. doi:10.1002/art.22471.
Holdcraft L, Assefi N, Buchwald D. Complementary and alternative medicine in fibromyalgia and related syndromes. Best Practices & Research. Clinical Rheumatology. 2003;17:667-683.
Baranowsky J, Klose P, Musial F, Haeuser W, Dobos G, Langhorst J. Qualitative systemic review of randomized controlled trials on complementary and alternative medicine treatments in fibromyalgia. Rheumatology International. 2009;30:1-21.
Carson JW, Carson KM, Jones KD, Bennett RM, Wright CL, Mist SD. A pilot randomized controlled trial of the Yoga of Awareness program in the management of fibromyalgia. Pain. 2010;151:530-539.
Wang C, Schmid CH, Rones R, et al . A randomized trial of tai chi for fibromyalgia. New England Journal of Medicine. 2010;363:743-754.
Inanici F, Yunus MB. History of fibromyalgia: past to present. Current Pain and Headache Reports. 2004;8:369-378.
Nebel MB, Gracely RH. Neuroimaging of fibromyalgia. Rheumatic Disease Clinics of North America. 2009;35:313-327.
Williams DA, Gracely RH. Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia. Arthritis Research & Therapy. 2006;8:224. doi:10.1186/ar2094.
Emad Y, Ragab Y, Zeinhom F, El-Khouly G, Abou-Zeid A, Rasker JJ. Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy. Journal of Rheumatology. 2008;35:1371-1377.
Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: new features for diagnosis. Pain. 1988;32:21-26.
Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal levels of substance P in patients with the fibromyalgia syndrome. Arthritis and Rheumatism. 1994;37:1593-1601.
Welin M, Bragee B, Nyberg F, Kristiansson M. Elevated substance P levels are contrasted by a decrease in met-enkephalin-arg-phe levels in CSF from fibromyalgia patients. Journal of Musculoskeletal Pain. 1995;3(Suppl. 1):4.
Bradley LA, Alberts KR, Alarcon GS, et al. Abnormal brain regional cerebral blood flow (rCBF) and cerebrospinal fluid (CSF) levels of substance P (SP) in patients and non-patients with fibromyalgia. Arthritis and Rheumatism. 1996;39(Suppl. 9):S212.
Giovengo SL, Russel IJ, Larson AA. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. The Journal of Rheumatology. 1999;26:1564-1569.
Harris RE, Sundgren PC, Craig AD, et al. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis and Rheumatism. 2009;60:3146-3152.
Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis and Rheumatism. 1992;35:1538-1539.
Legangneux E, Mora JJ, Spreux-Varoquaux O, et al. Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology (Oxford). 2001;40:290-296.
Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis and Rheumatism. 2008;59:961-967.
Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosomatic Medicine. 2004;66:837-844.
Epstein SA, Kay G, Clauw D, et al. Psychiatric disorders in patients with fibromyalgia: a multicenter investigation. Psychosomatics 1999;40:57-63.
Cohen H, Neumann L, Haiman Y, Matar MA, Press J, Buskila D. Prevalence of post-traumatic stress disorder in fibromyalgia patients; overlapping syndromes or post-traumatic fibromyalgia syndrome? Seminars in Arthritis and Rheumatism. 2002;32:38-50.
Dhungel KU, Malhortra V, Sarkar D, Prajapati R. Effect of alternate nostril breathing exercise on cardiorespiratory functions. Nepal Medical College Journal. 2008;10:25-27.
McCall T. Yoga as medicine: the yogic prescription for health and healing. New York: Random House; 2007.
Kabat-Zinn, J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain and illness. New York: Random House; 1990.
Sephton SE, Salmon P, Weissbecker I, et al. Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: results of a randomized clinical trial. Arthritis and Rheumatism. 2007;57:77-85.
Clark SR, Jones KD, Burckhardt CS, Bennett RM. Exercise for patients with fibromyalgia: risk versus benefits. Current rheumatology reports. 2001;3:135-146.
Mengshoel AM, Vollestad NK, Forre O. Pain and fatigue induced by exercise in fibromyalgia patients and sedentary healthy subjects. Clinical and Experimental Rheumatology. 1995;13:477-482.
Pearson N. Yoga for people in pain. International Journal of Yoga Therapy. 2008;18:77-86.
Grossman P, Tiefenthaler-Gilmer U, Raysz A, Kesper U. Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychotherapy and Psychosomatics. 2007;76:226-233.
National Fibromyalgia Association Web site. http://www.fmaware.org/site/News2?page=NewsArticle&id=8589
Lieb K, Ahlvers K, Dancker K, et al. Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men. Neuropsychopharmacology. 2002;27:1041-1049.
Andersen ML, Nascimento DC, Machado RB, Roizenblatt S, Moldofsky H, Tufik S. Sleep disturbance induced by substance P in mice. Behavioural Brain Research. 2006;167:212-218.
Marcus DA, Bernstein C, Rudy TE. Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome. Clinical Rheumatology. 2005;24:595-601. doi:10.1007/s10067-005-1121-x.
Watson NF, Buchwald D, Goldberg J, Noonan C, Ellenbogen RG. Neurologic signs and symptoms in fibromyalgia. Arthritis and Rheumatism. 2009;60:2839-2844.
Bennett R. The fibromyalgia impact questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clinical and Experimental Rheumatology. 2005;23(Suppl. 39):S154-S162.
Bennet R, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised fibromyalgia impact questionnaire (FIQ): validation and psychometric properties. Arthritis Research and Therapy. 2009;11:R120.
Burkhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. Journal of Rheumatology. 1991;18:728-733.
Busch AJ, Barber KA, Overend TJ, Peloso PMJ, Schacter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD003786.
Garcia-Campayo J, Magdalena J, Magallon R, Fernandez-Garcia E, Salas M, Andres E. A meta-analysis of the efficacy of fibromyalgia treatment according to level of care. Arthritis Research & Therapy. 2008;10:R81 doi:10.1186/ar2455.